General form of registration statement for all companies including face-amount certificate companies

Net Loss per Share (Tables)

v3.21.2
Net Loss per Share (Tables)
6 Months Ended 12 Months Ended
Jun. 30, 2021
Dec. 31, 2020
Earnings Per Share [Abstract]    
Schedule of Earnings Per Share Basic and Diluted Attributable to Common Stockholders
The following table sets forth the computation of basic and diluted net loss per share attributable to common stockholders:
 
                                                         
    
Six Months Ended June 30,
 
    
2021
    
2020
 
Numerator:
                 
Net loss
  
$
(46,560
  
$
(14,716
    
 
 
    
 
 
 
Denominator:
                 
Weighted-average shares used in computing basic and diluted net loss per share
  
 
10,663,811
 
  
 
10,319,534
 
    
 
 
    
 
 
 
Basic and diluted net loss per share
  
$
(4.37
  
$
(1.43
    
 
 
    
 
 
 
The following table sets forth the computation of basic and diluted net loss per share attributable to common stockholders:
 
 
  
Year Ended

December 31,
 
 
  
2020
 
  
2019
 
Numerator:
  
  
Net loss
  
$
(32,504
  
$
(32,319
  
 
 
 
  
 
 
 
Denominator:
  
  
Weighted-average shares used in computing basic and diluted net loss per share
  
 
10,323,839
 
  
 
10,306,255
 
  
 
 
 
  
 
 
 
Basic and diluted net loss per share
  
$
(3.15
  
$
(3.14
  
 
 
 
  
 
 
 
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share The Company excluded the following potential common shares, presented based on amounts outstanding at each period end, from the computation of diluted net loss per share for the six months ended June 30, because including them would have had an anti-dilutive effect:
 
                                                             
    
June 30,
 
    
2021
    
2020
 
Convertible preferred stock
(if-converted)
  
 
25,134,067
 
  
 
25,047,938
 
Warrants for the purchase of Series C convertible preferred stock
(if-converted)
  
 
—  
 
  
 
86,129
 
Warrants for the purchase of common stock
  
 
1,397,173
 
  
 
298,459
 
Convertible notes
(if-converted)
  
 
21,704,588
 
  
 
20,324,906
 
Stock options to purchase common stock
  
 
12,419,331
 
  
 
7,539,373
 
    
 
 
    
 
 
 
    
 
60,655,159
 
  
 
53,296,805
 
    
 
 
    
 
 
 
The Company excluded the following potential common shares, presented based on amounts outstanding at each period end, from the computation of diluted net loss per share for the years ended December 31, because including them would have had an anti-dilutive effect:
    
Year Ended

December 31,
 
    
2020
    
2019
 
Convertible preferred stock (if-converted)
     25,047,938        25,047,938  
Warrants for the purchase of Series C convertible preferred stock (if-converted)
     86,129        86,129  
Warrants for the purchase of common stock
     1,364,761        266,047  
Convertible notes (if-converted)
     20,060,646        19,820,736  
Stock options to purchase common stock
     10,762,690        8,281,881  
    
 
 
    
 
 
 
       57,322,164        53,502,731